Newsbrief: Feds prioritize 280E guidance, but mum on details
The Department of the Treasury included providing guidance for industry-hated tax rule 280E in the fiscal year from October 2026 through September 2027. In April, as the Trump administration rescheduled MED to Schedule III and geared up for DEA hearings on rescheduling REC, the Department said it would provide guidance on the implications for 280E which blocks companies selling Schedule I and II controlled substances from deducting business expenses on their taxes.
It has been tight-lipped since then as the . . .
Log in or become a WeedWeek Member to read this article.
